Antenatal suspicion of ischemic placental disease and coexistence of maternal and fetal placental disease: analysis of over 500 cases

May 25, 2017 by in GYNECOLOGY Comments Off on Antenatal suspicion of ischemic placental disease and coexistence of maternal and fetal placental disease: analysis of over 500 cases

Objective To investigate the antenatal suspicion of placental disease and the coexistence of maternal and fetal placental ischemic disease. Study Design A prospective cohort study on normally formed singleton infants…

read more

Sonography-based Automated Volume Count to estimate fetal urine production in twin-to-twin transfusion syndrome: comparison with Virtual Organ Computer-aided AnaLysis

May 25, 2017 by in GYNECOLOGY Comments Off on Sonography-based Automated Volume Count to estimate fetal urine production in twin-to-twin transfusion syndrome: comparison with Virtual Organ Computer-aided AnaLysis

Objective Sonography-based Automated Volume Count (SonoAVC) is an automated, operator-independent, 3-dimensional ultrasound technique. The study goal was to assess agreement between SonoAVC and Virtual Organ Computer-aided AnaLysis (VOCAL) for bladder…

read more

Quantitative analysis of renal vascularization in fetuses with urinary tract obstruction by three-dimensional power-Doppler

May 25, 2017 by in GYNECOLOGY Comments Off on Quantitative analysis of renal vascularization in fetuses with urinary tract obstruction by three-dimensional power-Doppler

Objective To evaluate the applicability of 3-dimensional evaluation of renal vascularization for predicting postnatal renal function in fetuses with suspected urinary obstruction. Study Design Fetuses were evaluated by 3-dimensional power-Doppler…

read more

Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody

May 25, 2017 by in GYNECOLOGY Comments Off on Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody

Objective We evaluated the expression of human trophoblast cell-surface marker (Trop-2) and the potential of hRS7, a humanized monoclonal anti-Trop-2 antibody, against treatment-refractory cervical cancer. Study Design Trop-2 expression was…

read more
Get Clinical Tree app for offline access